← All trials
NCT05497453
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 19, 2022
- Primary completion
- Jun 30, 2025
- Completion date
- Dec 31, 2028
- First posted
- Aug 11, 2022
- Last posted
- Aug 24, 2022
- Enrollment
- 190
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Omega TherapeuticsLead sponsor
- Omega TherapeuticsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.